GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Turk Ilac ve Serum Sanayi (IST:TRILC) » Definitions » COGS-to-Revenue

Turk Ilac ve Serumnayi (IST:TRILC) COGS-to-Revenue : 0.84 (As of Sep. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Turk Ilac ve Serumnayi COGS-to-Revenue?

Turk Ilac ve Serumnayi's Cost of Goods Sold for the three months ended in Sep. 2023 was ₺367 Mil. Its Revenue for the three months ended in Sep. 2023 was ₺436 Mil.

Turk Ilac ve Serumnayi's COGS to Revenue for the three months ended in Sep. 2023 was 0.84.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Turk Ilac ve Serumnayi's Gross Margin % for the three months ended in Sep. 2023 was 15.83%.


Turk Ilac ve Serumnayi COGS-to-Revenue Historical Data

The historical data trend for Turk Ilac ve Serumnayi's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Turk Ilac ve Serumnayi COGS-to-Revenue Chart

Turk Ilac ve Serumnayi Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
COGS-to-Revenue
Get a 7-Day Free Trial 0.43 0.54 0.50 0.82 0.75

Turk Ilac ve Serumnayi Quarterly Data
Dec17 Dec18 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.66 0.71 0.83 0.67 0.84

Turk Ilac ve Serumnayi COGS-to-Revenue Calculation

Turk Ilac ve Serumnayi's COGS to Revenue for the fiscal year that ended in Dec. 2022 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=625.338 / 833.438
=0.75

Turk Ilac ve Serumnayi's COGS to Revenue for the quarter that ended in Sep. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=366.896 / 435.882
=0.84

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Turk Ilac ve Serumnayi  (IST:TRILC) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Turk Ilac ve Serumnayi's Gross Margin % for the three months ended in Sep. 2023 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 366.896 / 435.882
=15.83 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Turk Ilac ve Serumnayi COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Turk Ilac ve Serumnayi's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Turk Ilac ve Serumnayi (IST:TRILC) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Bügduz Mah. Enver Pasa Cad., No: 8 Akyurt, Ankara, TUR, TR 06750
Turk Ilac ve Serum Sanayi is engaged in the production of human pharmaceuticals and vaccines.

Turk Ilac ve Serumnayi (IST:TRILC) Headlines

No Headlines